What is Celgene Corp.?

Celgene Corp., also known simply as Celgene, is a biopharmaceutical company that focuses on discovering, developing, and commercializing innovative therapies for the treatment of cancer and other severe inflammatory diseases. Established in 1986, the company became widely recognized for its commitment to transforming the lives of patients through advanced medical research and development. Celgene has developed several significant medications that have received approvals in various markets, catering to conditions like multiple myeloma and leukemia. In 2019, Celgene was acquired by Bristol-Myers Squibb, which allowed the latter to expand its oncology portfolio and enhance its capabilities in research and development. As a result, Celgene continues to play an essential role in the biopharmaceutical industry under the larger organization of Bristol-Myers Squibb. The company's dedication to scientific advancement and patient well-being remains at the core of its mission. For more information about Celgene and its current initiatives, the official website might provide helpful insights and contact details.